These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29461215)

  • 1. Paramagnetic Contrast Media: Hypersensitivity and Cross-Reactivity.
    Moreno Escobosa MC; Cruz Granados S
    J Investig Allergol Clin Immunol; 2018; 28(1):60-62. PubMed ID: 29461215
    [No Abstract]   [Full Text] [Related]  

  • 2. A delayed reaction to the magnetic resonance imaging contrast agent gadobutrol.
    Nagai H; Nishigori C
    J Allergy Clin Immunol Pract; 2017; 5(3):850-851. PubMed ID: 28153713
    [No Abstract]   [Full Text] [Related]  

  • 3. Gadoteridol-induced anaphylaxis - not a class allergy.
    Galera C; Pur Ozygit L; Cavigioli S; Bousquet PJ; Demoly P
    Allergy; 2010 Jan; 65(1):132-4. PubMed ID: 19796195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal Anaphylaxis Associated With the Gadolinium-Based Contrast Agent Gadoteridol (ProHance).
    Takahashi S; Takada A; Saito K; Hara M; Yoneyama K; Nakanishi H
    J Investig Allergol Clin Immunol; 2015; 25(5):366-7. PubMed ID: 26727767
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the safety and efficacy of gadoteridol injection (a low osmolal magnetic resonance contrast agent). Clinical trials report.
    DeSimone D; Morris M; Rhoda C; Lucas T; Zielonka J; Olukotun A; Carvlin M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S212-6; discussion S232-5. PubMed ID: 1808133
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnetic resonance imaging contrast agent related pulmonary edema: a case report.
    Demirhan A; Yasar Tekelioglu U; Akkaya A; Dagistan E; Suzi Ayhan S; Ozturk S; Yildiz I; Kocoglu H
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():110-2. PubMed ID: 23090824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous nodules, pain, and thrombophlebitis as an adverse reaction to gadolinium contrast media.
    Murphy KJ; Hansen R; Prince MR
    AJR Am J Roentgenol; 1997 Jul; 169(1):318-9. PubMed ID: 9207574
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Safety of Gadoteridol, Representative of the Macrocyclic Class of Gadolinium-Based Contrast Agents.
    Runge VM
    J Magn Reson Imaging; 2020 Mar; 51(3):869-870. PubMed ID: 31614049
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of Cross-Reactivity in Patients With Immediate Hypersensitivity Reactions to Gadobutrol.
    Gallardo-Higueras A; Moreno EM; Muñoz-Bellido FJ; Laffond E; Gracia-Bara MT; Macias EM; Campanon MV; de Arriba S; Martin C; Sobrino M; Davila I
    J Investig Allergol Clin Immunol; 2021 Dec; 31(6):504-506. PubMed ID: 34935616
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium induced anaphylaxis under general anesthesia in a patient with sickle cell disease.
    Salik I; Hernandez J
    J Clin Anesth; 2019 May; 54():47. PubMed ID: 30391454
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed reaction following gadolinium-based contrast agent application.
    Boehm I; Heverhagen JT
    Magn Reson Imaging; 2018 Jul; 50():10-11. PubMed ID: 29540332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions.
    Lerondeau B; Trechot P; Waton J; Poreaux C; Luc A; Schmutz JL; Paris C; Barbaud A
    J Allergy Clin Immunol; 2016 Feb; 137(2):633-635.e4. PubMed ID: 26428955
    [No Abstract]   [Full Text] [Related]  

  • 15. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
    Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
    Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reaction to intravenous gadoteridol.
    Shellock FG; Hahn HP; Mink JH; Itskovich E
    Radiology; 1993 Oct; 189(1):151-2. PubMed ID: 8372186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe anaphylactoid shock secondary to gadolinium contrast media.
    Simons CW; Benouni S; Gibbon G; Klaustermeyer W
    Ann Allergy Asthma Immunol; 2009 Oct; 103(4):359-60. PubMed ID: 19852205
    [No Abstract]   [Full Text] [Related]  

  • 18. First case report of acute generalized exanthematous pustulosis (AGEP) caused by gadolinium confirmed by patch testing.
    Bordel Gómez MT; Martín García C; Meseguer Yebra C; Zafra Cobo MI; Cardeñoso Álvarez ME; Sánchez Estella J
    Contact Dermatitis; 2018 Feb; 78(2):166-168. PubMed ID: 29341190
    [No Abstract]   [Full Text] [Related]  

  • 19. Late Diagnosis of Anaphylactic Reaction to Gadolinium-Based Contrast Media by Skin Tests 10 Years After Onset.
    Harr T; Jandus P
    J Investig Allergol Clin Immunol; 2018 Jun; 28(3):203-205. PubMed ID: 29939144
    [No Abstract]   [Full Text] [Related]  

  • 20. Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine.
    Meuli RA; Maeder P
    AJR Am J Roentgenol; 1996 Mar; 166(3):729. PubMed ID: 8623674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.